An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies

WASHINGTON (AP) -- An experimental COVID-19 vaccine from Novavax appears to offer strong protection in late-stage UK, South Africa studies.